2019 Carterra Symposia
View the slides of the presentations from the therapeutic antibody revolution in the post genomics era symposia.
Bristol-Myers Squibb, Boehringer Ingelheim and Other Biotechnology Companies to Present Use of Carterra’s Next Generation Antibody Screening Technology at Symposia Across the US and Europe
Rapid Adoption of Carterra’s LSA™ Instrument Drives European Expansion
Carterra® Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a Customer Experience Center (CEC) and office in Munich, Germany. Rapid European adoption of Carterra’s platform has fueled the need for the new office.
GEN Article: A Therapeutic Antibody Characterization Trinity Accelerates Drug Development
The three core applications of high throughput SPR that form the antibody characterization trinity are capture kinetics, epitope binning, and epitope mapping. Together, they provide a comprehensive characterization of antibody libraries with minimal sample consumption, enabling more confident decisions to be made earlier and obviating the need for preliminary ELISA screening.
BioTechniques Article on Accelerating Biotherapeutic Discovery with High Throughput SPR
High throughput SPR is revolutionizing antibody screening for drug discovery, allowing screening and characterization to be accomplished in the same step, at the very beginning of the discovery process.
SLAS Invites Yasmina Abdiche to Present Current Advancements in Antibody Discovery
Accelerate library-to-lead triage of antibody libraries using high throughput SPR.
Presentation and Poster at Antibody Engineering & Therapeutics
Daniel Bedinger, PhD, our West Coast Senior Field Applications Scientist spoke about accelerating your antibody discovery with high throughput Array SPR.
Carterra Continues Successful Antibody Discovery Seminars with new US East Coast Event
Industry leaders gather in Cambridge, MA on December 5, 2018 to discuss innovative methods for accelerating antibody discovery.
Presentation and Poster at PEGS Europe
Phil Leighton, PhD, Director of Molecular Biology at Ligand Pharmaceuticals spoke about epitope mapping of human antibodies from transgenic chickens.
Antibody Discovery Industry Leaders Speak at Carterra’s September 18, 2018 Seminar
Array SPR has facilitated a paradigm shift in antibody screening, enabling higher information content assays to be conducted earlier in the research pipeline to streamline lead selection. This essentially combines screening and detailed characterization in the same step.